PPH icon

VanEck Pharmaceutical ETF
PPH

Overview Fund Activity

49 hedge funds and large institutions have $121M invested in VanEck Pharmaceutical ETF in 2014 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 16 increasing their positions, 16 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
49
Holders Change
-5
Holders Change %
-9.26%
% of All Funds
1.42%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.06%
New
2
Increased
16
Reduced
16
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
Goldman Sachs
1
Goldman Sachs
New York
$41.8M
2
Barclays
2
Barclays
United Kingdom
$15.8M
3
Citigroup
3
Citigroup
New York
$3.22M
4
UCFA
4
United Capital Financial Advisors
Texas
$3.92M
5
Envestnet Asset Management
5
Envestnet Asset Management
Illinois
$4.57M

Top Sellers

1
CC
1
Columbia Capital
California
$0
2
Susquehanna International Group
2
Susquehanna International Group
Pennsylvania
$363K
3
B
3
Baird
Wisconsin
$0
4
AP
4
Advisors Preferred
Maryland
$0
5
RJA
5
Raymond James & Associates
Florida
$5.23M
Name Holding Trade Value Shares
Change 		Shares
Change %
B
51
Baird
Wisconsin
– -$1.43M -22,976 Closed
AP
52
Advisors Preferred
Maryland
– -$1.32M -21,355 Closed
VKH
53
Virtu KCG Holdings
New York
– -$732K -11,795 Closed
Northern Trust
54
Northern Trust
Illinois
– -$250K -4,030 Closed
HR
55
Howe & Rusling
New York
– -$6K -100 Closed
1 2
3